|
Originally published In Press as doi:10.1074/jbc.M101731200 on May 22, 2001
J. Biol. Chem., Vol. 276, Issue 31, 29163-29170, August 3, 2001
NADPH-Cytochrome P450 Oxidoreductase
STRUCTURAL BASIS FOR HYDRIDE AND ELECTRON TRANSFER*
Paul A.
Hubbard ,
Anna L.
Shen§,
Rosemary
Paschke ,
Charles B.
Kasper§, and
Jung-Ja P.
Kim ¶
From the Department of Biochemistry, Medical College
of Wisconsin, Milwaukee, Wisconsin 53226 and the § McArdle
Laboratory for Cancer Research, University of Wisconsin,
Madison, Wisconsin 53706
NADPH-cytochrome P450 oxidoreductase catalyzes
transfer of electrons from NADPH, via two flavin cofactors, to various
cytochrome P450s. The crystal structure of the rat reductase complexed
with NADP+ has revealed that nicotinamide access to
FAD is blocked by an aromatic residue (Trp-677), which stacks against
the re-face of the isoalloxazine ring of the flavin. To
investigate the nature of interactions between the nicotinamide, FAD,
and Trp-677 during the catalytic cycle, three mutant proteins were
studied by crystallography. The first mutant, W677X, has the last two
C-terminal residues, Trp-677 and Ser-678, removed; the second mutant,
W677G, retains the C-terminal serine residue. The third mutant has the
following three catalytic residues substituted: S457A, C630A, and
D675N. In the W677X and W677G structures, the nicotinamide moiety of NADP+ lies against the FAD isoalloxazine ring with a tilt
of ~30° between the planes of the two rings. These results,
together with the S457A/C630A/D675N structure, allow us to propose a
mechanism for hydride transfer regulated by changes in hydrogen bonding
and - interactions between the isoalloxazine ring and either the nicotinamide ring or Trp-677 indole ring. Superimposition of the mutant
and wild-type structures shows significant mobility between the two
flavin domains of the enzyme. This, together with the high degree of
disorder observed in the FMN domain of all three mutant structures,
suggests that conformational changes occur during catalysis.
*
This work was supported by National Institutes of Health
Grants GM 52682 (to J.-J. P. K.) and CA 22484 (to C. B. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1JA0, 1J9Z, and 1JA1) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence should be addressed. Tel.:
414-456-8479; Fax: 414-456-6510; E-mail: jjkim@mcw.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Hamdane, C. Xia, S.-C. Im, H. Zhang, J.-J. P. Kim, and L. Waskell
Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450
J. Biol. Chem.,
April 24, 2009;
284(17):
11374 - 11384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Ilagan, M. Tiso, D. W. Konas, C. Hemann, D. Durra, R. Hille, and D. J. Stuehr
Differences in a Conformational Equilibrium Distinguish Catalysis by the Endothelial and Neuronal Nitric-oxide Synthase Flavoproteins
J. Biol. Chem.,
July 11, 2008;
283(28):
19603 - 19615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Pandey, P. Kempna, G. Hofer, P. E. Mullis, and C. E. Fluck
Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase
Mol. Endocrinol.,
October 1, 2007;
21(10):
2579 - 2595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Marohnic, S. P. Panda, P. Martasek, and B. S. Masters
Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase
J. Biol. Chem.,
November 24, 2006;
281(47):
35975 - 35982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Panda, Y. T. Gao, L. J. Roman, P. Martasek, J. C. Salerno, and B. S. S. Masters
The Role of a Conserved Serine Residue within Hydrogen Bonding Distance of FAD in Redox Properties and the Modulation of Catalysis by Ca2+/Calmodulin of Constitutive Nitric-oxide Synthases
J. Biol. Chem.,
November 10, 2006;
281(45):
34246 - 34257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jachymova, P. Martasek, S. Panda, L. J. Roman, M. Panda, T. M. Shea, Y. Ishimura, J.-J. P. Kim, and B. S. S. Masters
Recruitment of governing elements for electron transfer in the nitric oxide synthase family
PNAS,
November 1, 2005;
102(44):
15833 - 15838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Higashimoto, H. Sakamoto, S. Hayashi, M. Sugishima, K. Fukuyama, G. Palmer, and M. Noguchi
Involvement of NADP(H) in the Interaction between Heme Oxygenase-1 and Cytochrome P450 Reductase
J. Biol. Chem.,
January 7, 2005;
280(1):
729 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Garcin, C. M. Bruns, S. J. Lloyd, D. J. Hosfield, M. Tiso, R. Gachhui, D. J. Stuehr, J. A. Tainer, and E. D. Getzoff
Structural Basis for Isozyme-specific Regulation of Electron Transfer in Nitric-oxide Synthase
J. Biol. Chem.,
September 3, 2004;
279(36):
37918 - 37927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Konas, K. Zhu, M. Sharma, K. S. Aulak, G. W. Brudvig, and D. J. Stuehr
The FAD-shielding Residue Phe1395 Regulates Neuronal Nitric-oxide Synthase Catalysis by Controlling NADP+ Affinity and a Conformational Equilibrium within the Flavoprotein Domain
J. Biol. Chem.,
August 20, 2004;
279(34):
35412 - 35425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Panda, S. Adak, D. Konas, M. Sharma, and D. J. Stuehr
A Conserved Aspartate (Asp-1393) Regulates NADPH Reduction of Neuronal Nitric-oxide Synthase: IMPLICATIONS FOR CATALYSIS
J. Biol. Chem.,
April 30, 2004;
279(18):
18323 - 18333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Knudsen, C. R. Nishida, S. D. Mooney, and P. R. O. de Montellano
Nitric-oxide Synthase (NOS) Reductase Domain Models Suggest a New Control Element in Endothelial NOS That Attenuates Calmodulin-dependent Activity
J. Biol. Chem.,
August 22, 2003;
278(34):
31814 - 31824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Elmore and T. D. Porter
Modification of the Nucleotide Cofactor-binding Site of Cytochrome P-450 Reductase to Enhance Turnover with NADH in Vivo
J. Biol. Chem.,
December 6, 2002;
277(50):
48960 - 48964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Adak, M. Sharma, A. L. Meade, and D. J. Stuehr
A conserved flavin-shielding residue regulates NO synthase electron transfer and nicotinamide coenzyme specificity
PNAS,
October 15, 2002;
99(21):
13516 - 13521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, P. Martasek, R. Paschke, T. Shea, B. S. Siler Masters, and J.-J. P. Kim
Crystal Structure of the FAD/NADPH-binding Domain of Rat Neuronal Nitric-oxide Synthase. COMPARISONS WITH NADPH-CYTOCHROME P450 OXIDOREDUCTASE
J. Biol. Chem.,
September 28, 2001;
276(40):
37506 - 37513.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|